Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis
Ayodeji Adegunsoye, Shehabaldin Alqalyoobi, A. Linderholm, Willis S. Bowman, Cathryn T. Lee, Janelle Vu Pugashetti, Nandini Sarma, Shwu‐Fan Ma, Angela Haczku, Anne I. Sperling, Mary E. Strek, Imre Noth, Justin M. Oldham
Topics & Concepts
MedicineIdiopathic pulmonary fibrosisBiomarkerInternal medicineOncologyProportional hazards modelGastroenterologyPopulationNintedanibPathologyLungBiologyEnvironmental healthBiochemistryInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisSarcoidosis and Beryllium Toxicity ResearchInflammatory Myopathies and Dermatomyositis